Intravenous Solutions Market Size, Share & Trends Analysis Report By Type (TPN, PPN), By Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), By End Use (Home, Hospitals, Infusion Centers), By Region, And Segment Forecasts, 2026 - 2033
Description
Intravenous Solutions Market Summary
The global intravenous solutions market size was estimated at USD 13.8 billion in 2025 and is projected to reach USD 28.2 billion by 2033, growing at a CAGR of 9.57% from 2026 to 2033. This growth is attributed to the increasing prevalence of diseases, such as neurological diseases, gastrointestinal diseases, and cancer.
IV solutions provide essential nutrients and are a main source of energy. The rising rate of premature births in developed countries such as the U.S. and the UK are further fueling the demand for intravenous (IV) solutions, as these nations have advanced neonatal care infrastructure that relies heavily on IV therapy. In these countries, factors such as increasing maternal age, higher rates of assisted reproductive technologies (ART), and chronic maternal conditions such as diabetes and hypertension have contributed to a growing number of preterm deliveries. For instance, according to Tommy's, the premature birth rate in England and Wales rose to 7.9% in 2022, up from 7.5% in 2021, marking two consecutive years of increase. Over 53,000 babies were born prematurely in 2022.
Malnutrition is one of the major drivers of the IV solutions market. According to the WHO, in 2022, 2.5 billion adults were overweight, with 890 million living with obesity, while 390 million were underweight. Globally, 149 million children under 5 were stunted, 45 million were wasted, and 37 million were overweight or obese. This high prevalence of malnutrition globally contributes to market growth. According to UNICEF, poor nutrition in the first 1,000 days of an infant’s life may lead to impaired cognitive ability and stunted growth. Starch, minerals, vitamins, amino acids, lipids, and other key substances must be present in an infant’s diet. These essential nutrients can be administered through parenteral nutrition, which is expected to boost the market. A high number of malnourished children and premature neonates that require these nutrients is expected to further propel the market.
Global Intravenous Solutions Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global intravenous solutions market report based on type, nutrient, end use, and region.
The global intravenous solutions market size was estimated at USD 13.8 billion in 2025 and is projected to reach USD 28.2 billion by 2033, growing at a CAGR of 9.57% from 2026 to 2033. This growth is attributed to the increasing prevalence of diseases, such as neurological diseases, gastrointestinal diseases, and cancer.
IV solutions provide essential nutrients and are a main source of energy. The rising rate of premature births in developed countries such as the U.S. and the UK are further fueling the demand for intravenous (IV) solutions, as these nations have advanced neonatal care infrastructure that relies heavily on IV therapy. In these countries, factors such as increasing maternal age, higher rates of assisted reproductive technologies (ART), and chronic maternal conditions such as diabetes and hypertension have contributed to a growing number of preterm deliveries. For instance, according to Tommy's, the premature birth rate in England and Wales rose to 7.9% in 2022, up from 7.5% in 2021, marking two consecutive years of increase. Over 53,000 babies were born prematurely in 2022.
Malnutrition is one of the major drivers of the IV solutions market. According to the WHO, in 2022, 2.5 billion adults were overweight, with 890 million living with obesity, while 390 million were underweight. Globally, 149 million children under 5 were stunted, 45 million were wasted, and 37 million were overweight or obese. This high prevalence of malnutrition globally contributes to market growth. According to UNICEF, poor nutrition in the first 1,000 days of an infant’s life may lead to impaired cognitive ability and stunted growth. Starch, minerals, vitamins, amino acids, lipids, and other key substances must be present in an infant’s diet. These essential nutrients can be administered through parenteral nutrition, which is expected to boost the market. A high number of malnourished children and premature neonates that require these nutrients is expected to further propel the market.
Global Intravenous Solutions Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global intravenous solutions market report based on type, nutrient, end use, and region.
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- Total Parenteral Nutrition
- Peripheral Parenteral Nutrition
- Nutrients Outlook (Revenue, USD Million, 2021 - 2033)
- Carbohydrates
- Vitamins & Minerals
- Single-dose Amino Acids
- Parenteral Lipid Emulsion
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Home
- Hospitals
- Infusion Centers
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
190 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Data Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Surgical Sealants And Adhesives Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing number of surgeries
- 3.2.1.2. Technological advancements in the industry
- 3.2.1.3. Growing demand for effective blood loss management in surgeries
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Availability of alternative methods and products
- 3.2.2.2. Stringent reimbursement policies
- 3.3. Surgical Sealants And Adhesives Market Analysis Tools
- 3.3.1. Industry Analysis – Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- Chapter 4. Surgical Sealants And Adhesives Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Surgical Sealants And Adhesives Market: Type Movement Analysis
- 4.3. Surgical Sealants And Adhesives Market by Type Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 – 2033 for the following
- 4.5. Natural or Biological Adhesives and Sealants
- 4.5.1. Natural or Biological Adhesives and Sealants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.1.1. Fibrin Sealants
- 4.5.1.1.1. Fibrin sealants market estimates and forecast, 2021 - 2033(USD Million)
- 4.5.1.2. Collagen based adhesives
- 4.5.1.2.1. Collagen based adhesives market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5.1.3. Gelatin-based Adhesives
- 4.5.1.3.1. Gelatin-based Adhesives market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5.1.4. Others
- 4.5.1.4.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6. Synthetic & Semi-synthetic Adhesives & Sealants
- 4.6.1. Synthetic & Semi-synthetic Adhesives & Sealants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.1.1. Urethane-based Adhesives
- 4.6.1.1.1. Urethane-based Adhesives market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6.1.2. Polyethylene Glycol Adhesives
- 4.6.1.2.1. Polyethylene Glycol Adhesives market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6.1.3. Cyanoacrylates
- 4.6.1.3.1. Cyanoacrylates market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Surgical Sealants And Adhesives Market: Indication Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Surgical Sealants And Adhesives Market: Indication Movement Analysis
- 5.3. Surgical Sealants And Adhesives Market by Indication Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2021 – 2033 for the following
- 5.5. Tissue Engineering
- 5.5.1. Tissue Engineering Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Tissue Sealing
- 5.6.1. Tissue Sealing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Hemostats
- 5.7.1. Hemostats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Surgical Sealants And Adhesives Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Surgical Sealants And Adhesives Market: Application Movement Analysis
- 6.3. Surgical Sealants And Adhesives Market by Application Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2021 – 2033 for the following
- 6.5. General Surgery
- 6.5.1. General Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Central Nervous System Surgery
- 6.6.1. Central Nervous System Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Cardiovascular Surgery
- 6.7.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8. Orthopedic Surgery
- 6.8.1. Orthopedic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.9. Cosmetic Surgery
- 6.9.1. Cosmetic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.10. Pulmonary Surgery
- 6.10.1. Pulmonary Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.11. Urology Surgery
- 6.11.1. Urology Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.12. Ophthalmology Surgery
- 6.12.1. Ophthalmology Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.13. Others
- 6.13.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Surgical Sealants And Adhesives Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Regional Chapter Surgical Sealants And Adhesives Market movement analysis
- 7.3. Surgical Sealants And Adhesives Market: Regional Estimates & Trend Analysis by type, Indication and Application
- 7.4. Market Size & Forecasts and Trend Analyses, 2021 – 2033 for the following
- 7.5. North America
- 7.5.1. North Surgical Sealants And Adhesives Market Estimates and Forecasts, 2021 – 2033 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. U.S. Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. Canada Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. Reimbursement scenario
- 7.5.4.5. Mexico Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Europe
- 7.5.6. Europe Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. UK
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Reimbursement scenario
- 7.5.7.5. UK Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.8. Germany
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Competitive Scenario
- 7.5.8.3. Regulatory Framework
- 7.5.8.4. Reimbursement scenario
- 7.5.8.5. Germany Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.9. France
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Competitive Scenario
- 7.5.9.3. Regulatory Framework
- 7.5.9.4. Reimbursement scenario
- 7.5.9.5. France Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.10. Italy
- 7.5.10.1. Key Country Dynamics
- 7.5.10.2. Competitive Scenario
- 7.5.10.3. Regulatory Framework
- 7.5.10.4. Reimbursement scenario
- 7.5.10.5. Italy Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.11. Spain
- 7.5.11.1. Key Country Dynamics
- 7.5.11.2. Competitive Scenario
- 7.5.11.3. Regulatory Framework
- 7.5.11.4. Reimbursement scenario
- 7.5.11.5. Spain Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.12. Denmark
- 7.5.12.1. Key Country Dynamics
- 7.5.12.2. Competitive Scenario
- 7.5.12.3. Regulatory Framework
- 7.5.12.4. Reimbursement scenario
- 7.5.12.5. Denmark Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.13. Sweden
- 7.5.13.1. Key Country Dynamics
- 7.5.13.2. Competitive Scenario
- 7.5.13.3. Regulatory Framework
- 7.5.13.4. Reimbursement scenario
- 7.5.13.5. Sweden Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.14. Norway
- 7.5.14.1. Key Country Dynamics
- 7.5.14.2. Competitive Scenario
- 7.5.14.3. Regulatory Framework
- 7.5.14.4. Reimbursement scenario
- 7.5.14.5. Norway Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. Japan Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. China Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement scenario
- 7.6.4.5. India Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement scenario
- 7.6.5.5. South Korea Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.6. Australia
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement scenario
- 7.6.6.5. Australia Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement scenario
- 7.6.7.5. Thailand Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Brazil Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. Argentina Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8. Middle East & Africa
- 7.8.1. Middle East & Africa Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement scenario
- 7.8.2.5. South Africa Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement scenario
- 7.8.3.5. Saudi Arabia Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. Reimbursement scenario
- 7.8.4.5. UAE Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Competitive Scenario
- 7.8.5.3. Regulatory Framework
- 7.8.5.4. Reimbursement scenario
- 7.8.5.5. Kuwait Surgical Sealants and Adhesives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. Johnson & Johnson (Ethicon)
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Artivion, Inc (CryoLife, Inc.)
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. C.R. Bard, Inc. (BD)
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Medtronic
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. B. Braun SE
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Terumo Corporation
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Cardinal Health
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Baxter
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Integra LifeSciences Corporation
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Stryker
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
